Authors:
Cambau, E
Bonnafous, P
Perani, E
Sougakoff, W
Ji, BH
Jarlier, V
Citation: E. Cambau et al., Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy, CLIN INF D, 34(1), 2002, pp. 39-45
Citation: Dm. Jiao et Bh. Ji, Photoinhibition in indica and japonica subspecies of rice (Oryza sativa) and their reciprocal F-1 hybrids, AUST J PLAN, 28(4), 2001, pp. 299-306
Authors:
Lounis, N
Bentoucha, A
Truffot-Pernot, C
Ji, BH
O'Brien, RJ
Vernon, A
Roscigno, G
Grosset, J
Citation: N. Lounis et al., Effectiveness of once-weekly rifapentine and moxifloxacin regimens againstMycobacterium tuberculosis in mice, ANTIM AG CH, 45(12), 2001, pp. 3482-3486
Authors:
Daniel, N
Lounis, N
Ji, BH
O'Brien, RJ
Vernon, A
Geiter, LJ
Szpytma, M
Truffot-Pernot, C
Hejblum, G
Grosset, J
Citation: N. Daniel et al., Antituberculosis activity of once-weekly rifapentine-containing regimens in mice - Long-term effectiveness with 6-and 8-month treatment regimens, AM J R CRIT, 161(5), 2000, pp. 1572-1577
Citation: Bh. Ji et Dm. Jiao, Relationships between D1 protein, xanthophyll cycle and photodamage-resistant capacity in rice (Orysa sativa L.), CHIN SCI B, 45(17), 2000, pp. 1569-1575
Authors:
Britton, W
Klatser, PR
Noordeen, SK
Gupte, MD
Grosset, JH
Nath, I
Kaplan, G
van Brakel, WH
Ji, BH
Brennan, PJ
Sengupta, U
Sow, SO
Gillis, TP
Smith, C
Ottenhoff, THM
Dockrell, HM
Modlin, RL
Citation: W. Britton et al., Use of a Mycobacterium leprae dipstick to classify patients with leprosy -Discussion, LEPROSY REV, 71, 2000, pp. S69-S72
Authors:
Ji, BH
Franzblau, SG
Rambukkana, A
Grosset, JH
Brennan, PJ
Citation: Bh. Ji et al., A rapid, microplate-based assay for evaluating the activity of drugs against Mycobacterium leprae, employing the reduction of Alamar Blue - Discussion, LEPROSY REV, 71, 2000, pp. S76-S76
Authors:
Gupte, MD
Ji, BH
Lockwood, DNJ
Grosset, JH
Van Brakel, WH
Citation: Md. Gupte et al., Combination of rifapentine-moxifloxacin-minocycline (PMM) for the treatment of leprosy - Discussion, LEPROSY REV, 71, 2000, pp. S87-S87
Authors:
Grosset, JH
van Brakel, WH
Ji, BH
Daumerie, D
Citation: Jh. Grosset et al., Current World Health Organization-sponsored studies in the chemotherapy ofleprosy - Discussion, LEPROSY REV, 71, 2000, pp. S90-S90
Authors:
Smith, C
Brennan, PJ
Lockwood, DNJ
Britton, W
Gupte, MD
van Brakel, WH
Ji, BH
Nunn, P
Rambukkana, A
Cole, S
Nath, I
Citation: C. Smith et al., Pathogenesis of nerve damage in leprosy: genetic polymorphism regulates the production of TNF alpha - Discussion, LEPROSY REV, 71, 2000, pp. S158-S160
Authors:
van Brakel, WH
Cole, S
Gillis, TP
Colston, MJ
Kaplan, G
Sengupta, U
Grosset, JH
Ji, BH
Citation: Wh. Van Brakel et al., Preliminary analysis of the genome sequence of Mycobacterium leprae - Discussion, LEPROSY REV, 71, 2000, pp. S164-S167
Authors:
van Brakel, WH
Ji, BH
Ginsberg, AM
Brennan, PJ
Lockwood, DNJ
Citation: Wh. Van Brakel et al., Leprosy research-setting priorities and facilitating collaborations: a personal perspective - Discussion, LEPROSY REV, 71, 2000, pp. S187-S187
Authors:
Consigny, S
Bentoucha, A
Bonnafous, P
Grosset, J
Ji, BH
Citation: S. Consigny et al., Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine againstMycobacterium leprae in mice, ANTIM AG CH, 44(10), 2000, pp. 2919-2921
Citation: Bh. Ji, Relapse of multibacillary leprosy after treatment with daily rifampin plusofloxacin for four weeks, INT J LEPR, 66(3), 1998, pp. 391-391